The abstract is read at the publisher; the summary is JClub's.
In a retrospective cohort of 70 neurocryptococcosis patients from Amazonas, Brazil, baseline fluconazole heteroresistance (HFL/MIC ≥ 8) was not significantly linked to relapse within 6 months.
- Why it matters: Relapse in cryptococcosis may be shaped by fungal subpopulations that persist after fluconazole exposure, but the clinical relevance of baseline heteroresistance is unclear.
- What they did: The first diagnostic cerebrospinal-fluid isolate from each patient was tested for fluconazole MIC and endpoint-based heteroresistance level (HFL) using broth microdilution; 43/70 (61.4%) met the operational HetR criterion HFL/MIC ≥ 8.
- The result: Among 69 with 6-month follow-up, relapse occurred in 12/42 (28.6%) with HetR isolates versus 4/27 (14.8%) with non-HetR isolates, with no significant association (conditional odds ratio 2.27; exact 95% CI 0.59–10.96; P = .248).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.